Currently out of the existing stock ratings of Cerena Chen, 6 are a BUY (100%).

Cerena Chen

Work Performance Price Targets & Ratings Chart

Analyst Cerena Chen, carries an average stock price target met ratio of 66.67% that have a potential upside of 25.73% achieved within 173 days. Previously, Cerena Chen worked at WELLS FARGO.

Cerena Chen’s has documented 12 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AMPH, Amphastar P at 14-May-2026.

Wall Street Analyst Cerena Chen

Analyst best performing recommendations are on AMPH (AMPHASTAR P).
The best stock recommendation documented was for AMPH (AMPHASTAR P) at 5/14/2026. The price target of $19 was fulfilled within 13 days with a profit of $1.7 (9.83%) receiving and performance score of 7.56.

Average potential price target upside

AMPH Amphastar P AXSM Axsome Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 26-Aug-2025

$20

$0.06 (0.30%)

1 months 6 days ago
(29-Jun-2026)

2/3 (66.67%)

$-0.71 (-3.43%)

26

Hold Since 08-Apr-2026

$20

$0.06 (0.30%)

$23

2 months 1 days ago
(03-Jun-2026)

4/7 (57.14%)

$1.88 (10.38%)

61

Buy Since 22-Nov-2024

$19

$-0.94 (-4.71%)

$35

2 months 21 days ago
(14-May-2026)

1/3 (33.33%)

$1.7 (9.83%)

13

Hold Since 21-Mar-2025

$21

$1.06 (5.32%)

$25

2 months 24 days ago
(11-May-2026)

12/19 (63.16%)

$2.55 (13.82%)

285

Buy Since 22-Oct-2025

$30

2 months 27 days ago
(08-May-2026)

9/13 (69.23%)

$9.77 (48.29%)

299

Show more analysts

Please expand the browser size to see the chart

Which stock is Cerena Chen is most bullish on?

Potential upside of $-0.94 has been obtained for AMPH (AMPHASTAR P)

What Year was the first public recommendation made by Cerena Chen?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?